Abstracts
of Key Research Articles
Nanobiotechnology-based drug delivery to the central nervous system
Jain KK
Neurodegener Dis. 2007; 4(4): 287-91
Active targeting of brain tumours using nanocarriers
Béduneau A, Saulnier P, Benoit JP
Biomaterials 2007; 28(33): 4947-67
On the rate and extent of drug delivery to the brain
Hammarlund-Udenaes M, Fridén M, Syvänen S, Gupta A
Pharm Res. 2007; Dec 5
The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity
Fagerholm U
Drug Discov Today. 2007; 12:1076-82
Genetics of aging: implications for drug discovery and development
Geesaman BJ
Am J Clin Nutr. 2006; 83(2): 466S-469S
The aging process: where are the drug opportunities?
Smith RG
Curr Opin Chem Biol. 2000; 4(4): 371-6
Growth hormone as an anti-aging therapy – do the benefits outweigh the risks?
Barkan AL
Nat Clin Pract Endocrinol Metab. 2007; 3(7): 508-9
Systems chemical biology
Oprea TI, Tropsha A, Faulon JL, Rintoul MD
Nat Chem Biol. 2007; 3: 447-50
Effective integration of systems biology, biomarkers, biosimulation and modelling in streamlining drug development
Krishna R, Schaefer HG, Bjerrum OJ
Eur J Pharm Sci. 2007; 31: 62-7
Understandiing diseases by a mouse click: the promise and potential of computational approaches in Systems Biology
Klauschen F, Angermann BR, Meier-Schellersheim M
Clin Exp Immunol. 2007; 149: 424-9
|
